Gracemed Formulations Private Limited

Gracemed Formulations Private Limited - healthcare in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24232UP2007PTC032726 Incorporated 10 January 2007 ROC Kanpur HQ Lucknow, Uttar Pradesh, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2021
₹41.18 Lakh
▼ 4% YoY
Net profit · FY 2021
₹84,715
Net margin 2.1%
EBITDA · FY 2021
₹86,870
EBITDA margin 2.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.08 Lakh
Issued & subscribed
Company age
19 yrs
Est. 2007
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Gracemed Formulations Private Limited

Data last updated:

Gracemed Formulations Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 10 January 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP2007PTC032726. Its GSTIN is 09AADCG1739N1Z8 (Uttar Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.08 Lakh. It is led by directors including Syed Ehtisham Husain and Rashid Husain.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 36 Kalyanpur (West) Ring Road, Lucknow, Uttar Pradesh, India – 226022.

As per the financials filed for FY 2021, the company reported a revenue of ₹41.18 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹84,715 (net margin 2.1%) and EBITDA of ₹86,870 (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Gracemed Formulations Private Limited
CIN U24232UP2007PTC032726
Registration Number 032726
Incorporation Date 10 January 2007
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    B – 36 Kalyanpur (West) Ring Road, Lucknow, Uttar Pradesh, India – 226022
  • Industry
    Healthcare, Other Hospital And Medical Care Activities
Comprehensive company report
Gracemed Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Gracemed Formulations Private Limited report

Financials, compliance, directors, charges, ownership and filings for Gracemed Formulations Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Gracemed Formulations Private Limited

The main business activity of Gracemed Formulations is trade. In detail, this covers retail trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG2Retail TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Gracemed Formulations Private Limited FY 2025 filings available

Gracemed Formulations Private Limited reported revenue of ₹41.18 Lakh (down 4% YoY) for FY 2021.

Revenue · FY 2021
₹41.18 Lakh ▼ 4%
Net profit · FY 2021
₹84,715 margin 2.1%
EBITDA · FY 2021
₹86,870 margin 2.1%

Compounded Annual Growth Rate (CAGR) of Gracemed Formulations Private Limited

Revenue CAGR growth
1 year
▼ 4%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 6%
5 years · compounded
▼ 13%

Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Gracemed Formulations Private Limited

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹86,870••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹84,715••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Gracemed Formulations Private Limited

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin2.1%••••••••••••••••
Net Profit Margin2.1%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gracemed Formulations are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Gracemed Formulations Private Limited

Gracemed Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Nextgen Pharmaceutical and Formulations Private Limited••••••••••••••••-Indore, Madhya Pradesh, India
Aorta Laboratories Private Limited••••••••••••••••-West Mumbai, Maharashtra, India
Zynext Pharmaceuticals Private Limited••••••••••••••••-Bhopal, Madhya Pradesh, India
Nascent Lifescience Private Limited••••••••••••••••-Ahmedabad, Gujarat, India
Puritan Pharmaceutical Private Limited••••••••••••••••-Patna, Bihar, India
Gracemed Formulations Private Limited this company••••••••••••••••-Lucknow, Uttar Pradesh, India
Prince Laboratories Private Limited••••••••••••••••-Hyderabad, Telangana, India
Kshipra Drugs Private Limited••••••••••••••••-Dewas, Madhya Pradesh, India
Acwin Pharma Private Limited••••••••••••••••-Sanand, Gujarat, India
A.I.Sure Pharmaceutical Private Limited••••••••••••••••-Pune City, Maharashtra, India
Durga Medical Foundation (DMF) Private Limited••••••••••••••••-Navi Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Gracemed Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of Gracemed Formulations Private Limited

Gracemed Formulations Private Limited is audited by KARIWALA&COMPANY for the financial year 2017.

NameStatusAppointment DateCessation Date
KARIWALA&COMPANYLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Gracemed Formulations Private Limited

Gracemed Formulations has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Syed Ehtisham HusainDirector06 Jul 201016 Years 3 MonthsCurrent
Rashid HusainDirector06 Jul 201016 Years 3 MonthsCurrent
Mohd Mustafa KhanDirector06 Jul 201016 Years 3 MonthsCurrent

Ownership and Shareholding of Gracemed Formulations Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Gracemed Formulations Private Limited

Gracemed Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Gracemed Formulations Private Limited

Employment history and EPFO contributions of people linked to Gracemed Formulations.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Gracemed Formulations Private Limited

Gracemed Formulations Private Limited has 9 board changes on record since 2010: 3 appointments and 6 cessations. The latest: Ahmar Shafi Siddiqui ceased to be Additional Director on 27 Apr 2013.

AGM
Gracemed Formulations Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Gracemed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Ahmar Shafi Siddiqui ceased to be Additional Director.
Ceased
Arif Masood ceased to be Director.
Ceased
Mohd Mustafa Khan ceased to be Additional Director.
Ceased
Rashid Husain ceased to be Additional Director.
Ceased
Syed Ehtisham Husain ceased to be Additional Director.
Appointed
Mohd Mustafa Khan was appointed as Director.
Ceased
Rajnish Bhardwaj ceased to be Director.
Appointed
Rashid Husain was appointed as Director.
Appointed
Syed Ehtisham Husain was appointed as Director.
Incorporation
10 Jan 2007
Gracemed Formulations Private Limited was registered on 10 Jan 2007 with Roc Kanpur & aged 19 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Gracemed Formulations Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Gracemed Formulations Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Gracemed Formulations Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Gracemed Formulations Private Limited

Gracemed Formulations has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AADCG1739N1Z8Uttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Gracemed Formulations Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gracemed Formulations Private Limited

Gracemed Formulations is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 10 January 2007 (19+ years old) and is registered under CIN U24232UP2007PTC032726.

Gracemed Formulations reported revenue of ₹41.18 Lakh for FY 2021 (down 4% YoY).

Gracemed Formulations has 3 current directors:

Gracemed Formulations reported a net profit of ₹84,715 (net margin 2.1%) and EBITDA of ₹86,870 (EBITDA margin 2.1%) for FY 2021, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Gracemed Formulations is 10% over five years. In the latest year (FY 2021) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Gracemed Formulations is 09AADCG1739N1Z8, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Gracemed Formulations is U24232UP2007PTC032726. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gracemed Formulations was incorporated on 10 January 2007, making it 19+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Gracemed Formulations by revenue are Nextgen Pharmaceutical and Formulations Private Limited, Aorta Laboratories Private Limited, Zynext Pharmaceuticals Private Limited, Nascent Lifescience Private Limited, Puritan Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Formulations).

Ahmar Shafi Siddiqui ceased to be Additional Director on 27 Apr 2013. Arif Masood ceased to be Director on 27 Apr 2013. Mohd Mustafa Khan ceased to be Additional Director on 30 Sep 2011. Gracemed Formulations has 9 board changes on record in total.

The registered office of Gracemed Formulations is at B – 36 Kalyanpur West Ring Road, Lucknow, Uttar Pradesh, India – 226022.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available